We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $39.6 · 5 analysts
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Stored first · Google News · Yahoo Finance (English)
CONMED Board Refresh And Governance Changes Feed Into Valuation Debate - Yahoo Finance
CONMED Board Refresh And Governance Changes Feed Into Valuation Debate Yahoo Finance
CONMED Board Refresh And Governance Changes Feed Into Valuation Debate
CONMED Corporation Executes First Omnibus Amendment and Increased Facility Activation Notice to Eighth Amended and Restated Credit Agreement - Minichart
CONMED Corporation Executes First Omnibus Amendment and Increased Facility Activation Notice to Eighth Amended and Restated Credit Agreement Minichart
Here's Why You Should Retain CONMED Stock in Your Portfolio Now - TradingView
Here's Why You Should Retain CONMED Stock in Your Portfolio Now TradingView
Here's Why You Should Retain CONMED Stock in Your Portfolio Now
Conmed secures $450 million term loan facility to repurchase convertible notes - Investing.com UK
Conmed secures $450 million term loan facility to repurchase convertible notes Investing.com UK
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 04. 29. | After market close (AMC) | $1.1 | — | — | $337.46M | — | Scheduled |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $3.17 | — | — | $961.07M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $1.59 | — | — | $644.37M | Reported |
| FY2025 Q1 | 2024. 03. 31. | Time TBD | — | $0.63 | — | — | $312.27M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 19. | B of A Securities | — | Maintain | Neutral → Neutral | — | B of A Securities: Neutral |
| 2026. 05. 01. | Wells Fargo | — | Maintain | Equal-Weight → Equal-Weight | — | Wells Fargo: Equal-Weight |
Compare a firm's past rating changes and its actions on other stocks in the same sector.
As of FY2025Q3 · Source: SEC/DART + price data
Filings, earnings, and institutional changes summarized in one paragraph, with source links.
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 782,540 | $27.67B | 0.02% | — | New position |
| 2 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 271,840 | $11.04B | 0.02% | — | New position |
See new positions, full exits, and weight changes.